DABIGATRAN for Percutaneous coronary intervention: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where DABIGATRAN was used for Percutaneous coronary intervention.
Most Reported Side Effects for DABIGATRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 210 | 10.1% | 44 | 157 |
| Hypotension | 167 | 8.0% | 11 | 139 |
| Atrial fibrillation | 150 | 7.2% | 3 | 110 |
| Drug interaction | 143 | 6.9% | 7 | 95 |
| Haemorrhage | 141 | 6.8% | 21 | 84 |
| Anaemia | 131 | 6.3% | 12 | 113 |
| Dizziness | 123 | 5.9% | 6 | 97 |
| Acute kidney injury | 120 | 5.8% | 14 | 99 |
| Drug ineffective | 118 | 5.7% | 10 | 88 |
| Fall | 117 | 5.6% | 3 | 97 |
| Gastric haemorrhage | 111 | 5.3% | 0 | 94 |
| Melaena | 100 | 4.8% | 5 | 90 |
| Haematuria | 85 | 4.1% | 2 | 62 |
| Cardiac failure | 79 | 3.8% | 7 | 65 |
| Dyspnoea | 76 | 3.7% | 7 | 61 |
Other Indications for DABIGATRAN
Atrial fibrillation (997)
Product used for unknown indication (478)
Anticoagulant therapy (127)
Deep vein thrombosis (58)
Cerebrovascular accident prophylaxis (48)
Pulmonary embolism (43)
Cerebrovascular accident (35)
Thrombosis prophylaxis (32)
Prophylaxis (23)
Atrial flutter (17)
Other Drugs Used for Percutaneous coronary intervention
PRASUGREL (376)
CLOPIDOGREL BISULFATE (356)
TICAGRELOR (297)
ASPIRIN (227)
BIVALIRUDIN (159)
CANGRELOR (94)
HEPARIN (86)
ABCIXIMAB (49)
INVESTIGATIONAL PRODUCT (46)
IODIXANOL (29)